Periodontal Disease Combination Therapy: Enhancing Clinical Outcomes with Antimicrobials Beyond Chlorhexidine

Periodontal disease, a chronic inflammatory condition affecting the supporting structures of the teeth, is primarily caused by microbial infection. While traditional mechanical therapies, such as scaling and root planing (SRP), effectively reduce bacterial load and inflammation, they may not fully eliminate the periodontal pathogens, particularly in deeper periodontal pockets.  The management of periodontal disease often requires a multifaceted approach that includes mechanical debridement, patient education, and adjunctive therapies. Among these, combination therapy, mainly systemic and local antimicrobials, has gained traction as a strategy to enhance clinical outcomes.

 

 

Combination Therapy

 

Combination therapy is the simultaneous or sequential use of multiple treatment modalities to achieve a synergistic effect. This approach targets various aspects of periodontal disease, including microbial factors, host response, and tissue regeneration. Combination therapy can tackle multiple facets of periodontal disease, such as bacterial infection, inflammation, and tissue regeneration by integrating different agents and approaches. This approach often results in enhanced clinical outcomes compared to single-agent therapy. A typical combination might include mechanical debridement followed by applying a controlled-release antimicrobial like Arestin or Atridox. This approach leverages the initial debridement to remove debris and plaque while the antimicrobial agents address residual bacterial infection.

 

 

Antimicrobials Used in Combination Therapy

 

Several systemic and local antimicrobials have been employed in combination therapies for periodontal disease.  the most common agents and their specific applications are:

 

Essential Oils

Essential oils are natural plant extracts known for their antimicrobial properties. While research is ongoing, they may provide an alternative for patients with antibiotic sensitivities. Essential oils such as thymol, menthol, eucalyptol, and methyl salicylate are commonly used in the context of periodontal disease. These oils are often found in mouth rinses and gels. Essential oils disrupt bacterial cell membranes and inhibit the growth of periodontal pathogens. They possess broad-spectrum antimicrobial activity, targeting a range of bacteria involved in periodontal infections.

 

 Applications:

    • Mouth Rinses: Essential oils are formulated into mouth rinses to help reduce plaque and gingivitis. Products like Listerine® utilize these ingredients.
    • Gels: Topical gels containing essential oils can be applied directly to the gingival tissue to provide localized antimicrobial action.

 

 

Iodine-Containing Compounds

Iodine and its compounds, such as iodine tinctures and povidone-iodine, have been utilized in dental care for their potent antimicrobial effects. Iodine is a broad-spectrum antimicrobial agent that penetrates bacterial cell walls and disrupts vital cellular functions. It effectively kills bacteria, fungi, and viruses.

 

 Applications:

    • Topical Applications: Povidone-iodine solutions can be applied topically to periodontal pockets to reduce bacterial load during scaling and root planing.
    • Irrigants: Iodine solutions can also be used as irrigants during periodontal therapy to enhance debridement and infection control.

 

 

Metronidazole

Metronidazole is an antibiotic with significant efficacy against anaerobic bacteria and certain protozoa. It is often used in conjunction with other treatments for its combined effects. Metronidazole works by entering bacterial cells and disrupting DNA synthesis, leading to bacterial cell death. It is particularly effective against the anaerobic bacteria commonly found in periodontal infections.

 

 Applications:

    • Systemic Therapy: Metronidazole is typically administered orally in cases of severe periodontal disease or in conjunction with other antibiotics.
    • Topical Gel: Metronidazole can also be applied directly to periodontal pockets in a topical gel form.

 

 

Tetracycline (Doxycycline)

Doxycycline is a tetracycline antibiotic known for its use in managing periodontal diseases. It possesses both antimicrobial and anti-inflammatory properties. Doxycycline prevents the bacteria from producing proteins, which stops their growth and replication. Additionally, it has anti-inflammatory effects that help reduce tissue breakdown in periodontal disease.

 

 Applications:

    • Systemic Therapy: Doxycycline is often prescribed orally in cases of aggressive periodontitis or as part of a combination therapy.
    • Topical Application (Atridox): Atridox is a doxycycline-based gel used as a controlled-release antimicrobial agent for treating periodontal disease. It offers targeted delivery of the antibiotic directly into periodontal pockets.
    • Procedure: During periodontal therapy, the gel is injected into periodontal pockets following scaling and root planing. The gel solidifies into a biodegradable matrix, providing continuous antibiotic delivery to the site.
    • Benefits: This localized delivery reduces the need for systemic antibiotics and minimizes potential side effects. It also enhances the overall effectiveness of periodontal treatment by directly targeting the infection.

 

Minocycline

Minocycline is another tetracycline derivative used in periodontal treatment. It is known for its extended-release formulation and effective periodontal management. Similar to doxycycline, minocycline inhibits bacterial protein synthesis, but it is noted for its ability to penetrate deeper into periodontal tissues and its extended-release formulation.

 

Applications:

    • Topical (Arestin): Minocycline is available in powder form, such as Arestin®, directly applied to periodontal pockets to provide localized antimicrobial action and promote healing. Like Atridox, Arestin offers localized treatment with prolonged drug release.
    • Procedure: Arestin is applied to periodontal pockets following scaling and root planing. The powder forms a gel-like substance when in contact with moisture, allowing for prolonged contact with the infected tissue.
    • Benefits: The extended-release formulation provides continued antimicrobial activity, reducing bacterial load and promoting healing in the treated area. It is particularly useful in managing pockets that are resistant to conventional treatment.

 

 

Chlorhexidine (PerioChip)

PerioChip contains chlorhexidine, an antiseptic with broad-spectrum antimicrobial properties. The chip releases chlorhexidine slowly over time, providing localized antimicrobial effects.

 

Application:

    • Procedure: After scaling and root planing, the chip is placed directly into periodontal pockets. It gradually releases chlorhexidine, which helps to reduce bacterial populations and inflammation.
    • Benefits: The sustained release of chlorhexidine aids in controlling infection and promoting periodontal healing. It is particularly useful in cases where additional antimicrobial intervention is required.

 

 

Clinical outcomes

Numerous clinical studies have demonstrated that combination therapy significantly enhances treatment outcomes in periodontal disease. Key improvements noted in the literature include:

  • Reduction in probing depths
  • Improved clinical attachment levels
  • Decreased bacterial load

 

 

Conclusion

Combination therapies represent a significant evolution in the management of periodontal disease. Combination therapy represents a promising strategy for managing periodontal disease, particularly when mechanical debridement alone may fall short. Systemic and local antimicrobials have been shown to enhance clinical outcomes, leading to improved patient prognoses. Essential oils, iodine-containing compounds, metronidazole, doxycycline, and minocycline each offer unique benefits and mechanisms of action that can be tailored to individual patient needs.  Dentists must evaluate these options based on the specific requirements of the periodontal condition, patient preferences, and potential side effects to provide optimal care and improve periodontal health outcomes.

 

Thanks for reading our latest blog! If you've got a topic you'd like to see us tackle next, please submit your suggestion to our blog writing team of dental professionals at blogs@maxill.com. 

Maryanne Ferree RDH, BS, PHDHP

Maryanne Ferree, BS, RDH, PHDHP, CDIPC from Pittsburgh, Pennsylvania, is a registered dental hygienist with over 39 years of experience. She has ventured into many facets of dental hygiene, including clinical care, public health, and education. She is currently a clinical faculty member in the Department of Periodontics and Preventive Dentistry at the University of Pittsburgh School of Dental Medicine focusing her clinical teaching on Periodontal Instrumentation. She has been excited to step into the role of KOL and blogger to share her enthusiasm for infection control in the dental setting, OSHA compliance training, and periodontal disease therapy.

 

References

  1. Mombelli, A., & Samaranayake, L. P. (2004). Topical and systemic antibiotics in the management of periodontal diseases. International dental journal, 54(1), 3–14. https://doi.org/10.1111/j.1875-595x.2004.tb00246.x
  2. Kalsi, R., Vandana, K. L., & Prakash, S. (2011). Effect of local drug delivery in chronic periodontitis patients: A meta-analysis. Journal of Indian Society of Periodontology, 15(4), 304–309. https://doi.org/10.4103/0972-124X.92559
  3. Teughels, W., Feres, M., Oud, V., Martín, C., Matesanz, P., & Herrera, D. (2020). Adjunctive effect of systemic antimicrobials in periodontitis therapy: A systematic review and meta‐analysis. Journal of Clinical Periodontology, 47(S22), 257–281. https://doi.org/10.1111/jcpe.13264